Latest news from Pharmetheus
Pharmetheus continues to monitor the challenges presented by the COVID-19 pandemic and its effects on our company and in the field of clinical drug development. Read more about our approach and latest updates here.
Welcome Quentin Leirens!
Welcome Anaïs Glatard!
Benefits with modeling circulating tumor cell counts as a predictor of overall survival
Welcome Ninni Sylenius!
Welcome Viviana Moroso!
Welcome Mikael Ringh!
Pharmetheus presence at ISTH 2020 congress
New service: Quantitative Systems Pharmacology (QSP)
Congratulations Prof. Andrew Hooker!
Welcome Henrik Hellerstedt!
Covid-19 Pharmacology Resource
We have now joined the COVID-19 Pharmacology Resource Center. Conquering COVID-19 with clinical pharmacology, innovation, and collaboration.
More information available at the Covid-19 Pharmacology Resource web page
Pharmetheus Approach to COVID-19 related challenges in clinical trial conduct
Pharmetheus is currently working with a number of clients to address the impact of the current COVID-19 epidemic to their ongoing clinical drug development programs. We would like to share our high level approach with the community at large. We see the current situation as both a challenge to our industry/sector but also an opportunity for appropriate and quantitative approaches to mitigate upon these challenges. We believe there are "fit for purpose" options for a broad range of plausible scenarios in clinical trial conduct that have emerged or could emerge.
See our approach
Welcome Julie Janssen and Anna Pousette!
We are very happy to welcome two new team members, Julie Janssen, MIDD consultant, and Anna Pousette, Contracts Manager. Julie's research experience includes the application of pharmacometrics in the clinical setting, chemotherapy and targeted therapies, as well as special patient populations (e.g. pediatrics and pregnancy). Julie is based in the Netherlands. See Julie's bio here. Anna has long experience of project coordination and procurement. Anna will work from our Uppsala office in Sweden. See Anna's bio here.
Open Systems Pharmacology publication
If you are interested in our services, please fill out the form below.
Our way of working, with traceability and accountability from data programming to report delivery, is well adapted to, and highly compatible with, current regulatory requirements.